| Long name: |
MEF2D Primary Polyclonal Antibody |
| Also known as: |
MEF2D PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
MEF2D |
| Specificity: |
This is a highly specific antibody against MEF2D |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human MEF2D |
| Gene ID number: |
4209 |
| Swiss Prot: |
Q14814 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
5'-YTA[AT](4)TAR-3', Mediates cellular functions not only in skeletal and cardiac muscle development, Plays a critical role in the regulation of neuronal apoptosis (By similarity), Plays diverse roles in the control of cell growth, but also in neuronal differentiation and survival, found in numerous muscle-specific, growth factor- and stress-induced genes, survival and apoptosis via p38 MAPK signaling in muscle-specific and/or growth factor-related transcription, Transcriptional activator which binds specifically to the MEF2 element |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
MEF2D, Myocyte-specific enhancer factor 2D |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
MEF2D |
| Short name: |
MEF2D Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
myocyte enhancer factor 2D (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
DNA-templated and biological process this GO :0006355 and regulation of transcription, DNA-templated and biological process this GO :0006366 and transcription from RNA polymerase II promoter and biological process this GO :0006915 and apoptotic process and biological process this GO :0007399 and nervous system development and biological process this GO :0007512 and adult heart development and biological process this GO :0007517 and muscle organ development and biological process this GO :0033613 and activating transcription factor binding and molecular function this GO :0035914 and skeletal muscle cell differentiation and biological process this GO :0042826 and histone deacetylase binding and molecular function this GO :0043231 and intracellular membrane-bounded organelle and cellular component this GO :0045893 and positive regulation of transcription, DNA-templated and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0046983 and protein dimerization activity and molecular function, MEF2D and IDBG-103519 and ENSG00000116604 and 4209, MEF2D and IDBG-631559 and ENSBTAG00000046545 and 100336730, Mef2d and IDBG-159892 and ENSMUSG00000001419 and 17261, nuclei, protein dimerization activity, this GO :0000977 and RNA polymerase II regulatory region sequence-specific DNA binding and molecular function this GO :0000981 and sequence-specific DNA binding RNA polymerase II transcription factor activity and molecular function this GO :0001649 and osteoblast differentiation and biological process this GO :0001958 and endochondral ossification and biological process this GO :0002062 and chondrocyte differentiation and biological process this GO :0003677 and DNA binding and molecular function this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0006351 and transcription, this GO :0000977 : RNA polymerase II regulatory region sequence-specific DNA binding, this GO :0000977 : RNA polymerase II regulatory region sequence-specific DNA binding and also this GO :0000981 : sequence-specific DNA binding RNA polymerase II transcription factor activity and also this GO :0003677 : DNA binding and also this GO :0003700 : sequence-specific DNA binding transcription factor activity and also this GO :0005515 : protein binding and also this GO :0033613 : activating transcription factor binding and also this GO :0042826 : histone deacetylase binding and also this GO :0046983 : protein dimerization activity, this GO :0000981 : sequence-specific DNA binding RNA polymerase II transcription factor activity, this GO :0003677 : DNA binding, this GO :0003700 : sequence-specific DNA binding transcription factor activity, this GO :0005515 : protein binding, this GO :0033613 : activating transcription factor binding, this GO :0042826 : histone deacetylase binding, this GO :0046983 : protein dimerization activity, myocyte enhancer factor 2D |
| Identity: |
6997 |
| Gene: |
MEF2D |
More about : MEF2D |
| Long gene name: |
myocyte enhancer factor 2D |
| Locus: |
1q22 |
| Discovery year: |
1995-02-08 |
| GenBank acession: |
BC054520 |
| Entrez gene record: |
4209 |
| Pubmed identfication: |
8269842 |
| RefSeq identity: |
NM_005920 |
| Classification: |
Myocyte enhancer factor 2 proteins MADS box family |
| Havana BLAST/BLAT: |
OTTHUMG00000033095 |